NUVB
Nuvation Bio Inc
NYSE: NUVB · HEALTHCARE · BIOTECHNOLOGY
$4.34
-4.82% today
Updated 2026-04-29
Market cap
$1.51B
P/E ratio
—
P/S ratio
23.99x
EPS (TTM)
$-0.60
Dividend yield
—
52W range
$2 – $10
Volume
4.2M
Nuvation Bio Inc (NUVB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-81.30%
ROE
-53.20%
ROA
-23.50%
Debt/equity
0.18x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | — | $-992000.00 | — | — | — |
| 2019 | — | $-33.55M | — | — | — |
| 2020 | $0.00 | $-41.66M | — | — | — |
| 2021 | $0.00 | $-86.85M | — | — | — |
| 2022 | $0.00 | $-104.20M | — | — | — |
| 2023 | $0.00 | $-75.80M | — | — | — |
| 2024 | $7.87M | $-567.94M | 10.10% | -7,527.33% | -7,213.76% |
| 2025 | $62.90M | $-204.63M | 86.58% | -338.72% | -325.31% |